0001144204-18-008909.txt : 20180214
0001144204-18-008909.hdr.sgml : 20180214
20180214162623
ACCESSION NUMBER: 0001144204-18-008909
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20171231
FILED AS OF DATE: 20180214
DATE AS OF CHANGE: 20180214
EFFECTIVENESS DATE: 20180214
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Knoll Capital Management, LP
CENTRAL INDEX KEY: 0001325083
IRS NUMBER: 133476926
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-11424
FILM NUMBER: 18612677
BUSINESS ADDRESS:
STREET 1: 5 EAST 44TH STREET
STREET 2: 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212-808-7474
MAIL ADDRESS:
STREET 1: 5 EAST 44TH STREET
STREET 2: 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001325083
XXXXXXXX
12-31-2017
12-31-2017
false
Knoll Capital Management, LP
5 East 44th Street
12th floor
New York
NY
10017
13F HOLDINGS REPORT
028-11424
N
Fred Knoll
President
646-590-3960
/s/ Fred Knoll
New York
NY
02-14-2018
0
12
113433
INFORMATION TABLE
2
infotable.xml
Abeona Therapeutics Inc
COM
00289Y107
37402
2359767
SH
SOLE
2359767
0
0
Advaxis Inc.
W EXP 07/15/201
007624117
113
112500
SH
SOLE
112500
0
0
Aldeyra Therapeutics Inc
COM
01438T106
844
124096
SH
SOLE
124096
0
0
Ampio Pharmaceuticals Inc.
COM
03209T109
10564
2595484
SH
SOLE
2595484
0
0
Anavex Life Sciences Corp
COM NEW
032797300
2332
724205
SH
SOLE
724205
0
0
Biohaven Pharmactl Hldg Co L
COM
G11196105
21779
807224
SH
SOLE
807224
0
0
Corbus Pharmaceuticals HLDGS
COM
21833P103
27385
3856985
SH
SOLE
3856985
0
0
Evoke Pharma Inc
COM
30049G104
622
275000
SH
SOLE
275000
0
0
Krystal Biotech Inc
COM
501147102
3156
300000
SH
SOLE
300000
0
0
Soligenix Inc.
COM
834223307
1835
870000
SH
SOLE
870000
0
0
Vascular Biogenics LTD
COM
M96883109
6367
896771
SH
SOLE
896771
0
0
Volition RX LTD
COM
928661107
1034
351538
SH
SOLE
351538
0
0